Equivariant Graph Attention Networks with Structural Motifs for Predicting Cell Line -Specific Synergistic Drug Combinations
JSHS · 2024
Overview
Cancer is the second leading cause of death, behind heart disease, with chemotherapy as one of the primary forms of treatment. As a result, researchers are turning to drug combination therapy. However, current methods of screening such as in vivo and in vitro are inefficient due to time and monetary costs. In silico methods have become increasingly important, but current methods of screening drug combinations are inaccurate and generalize poorly. In this paper, I employ a geometric deep-learning model based on a rotational and translation equivariant graph attention network with structural motifs. Additionally, the gene expression of the cancer cell line is used as an input to a multi -layer perception to classify the synergistic drug combinations based on ea ch cancer cell line. I compared the proposed geometric deep learning framework to state -of-the-art methods and achieved greater performances on all 12 benchmark tasks performed on the DrugComb dataset. Specifically, the proposed framework performs superior to other state-of-the-art methods by greater than an accuracy of 28%. Based on these results, I believe that the equivariant graph attention network's capabilities of learning geometric data account for large performance improvements. The model's ability to generalize to foreign drugs is thought to be due to the structural motifs better representing the molecule. Overall, I believe that the proposed equivariant geometric deep-learning framework is an effective tool for virtually screening anticancer drug combinations for further validation in a wet lab environment.
Competition history
- JSHS 2024
Resources
Related projects
ISEF · 2023
PROSynMOGN: Enhancing Molecular Graph Neural Networks Toward Predicting Synergistic Cancer Drug Combinations Driven by Protein Expression
ISEF · 2016
Predictive Modeling of Optimal Cancer Therapies
ISEF · 2014
Rational Discovery and Optimization of Synergistic Chemotherapy Combinations: A Novel Framework Integrating Gene Perturbation Analysis and Machine Learning Algorithms
ISEF · 2022
CANDraGAT: A Hybrid Fragment-Based Graph Attention Network To Improve Cancer Drug Response Prediction
ISEF · 2026
The Virtual Cell 2.0: Expanding Precision and Personalized Cancer Therapy Through AI-Powered Simulation
JSHS · 2023
WYOMING AND COLORADO Pharmacophore Analysis Driven Deep Neural Networks to Discover Novel Anticancer Drug Combinations
ISEF · 2024
GraphChem: A Soft Graph Mixture of Experts Based Adversarial Variational Spectral Graph Autoencoder for De Novo Drug Design & Other Pharmacological Objectives
ISEF · 2026
From SMILES to Synergy: Biologically-Enriched Drug Screening for Synergistic Combination Therapy in Tamoxifen Resistant ER+ Breast Cancer
Closest projects by meaning, across every fair and year in the corpus.